» Articles » PMID: 36238488

Identification of Candidate MicroRNA-mRNA Subnetwork for Predicting the Osteosarcoma Progression by Bioinformatics Analysis

Overview
Publisher Hindawi
Date 2022 Oct 14
PMID 36238488
Authors
Affiliations
Soon will be listed here.
Abstract

Osteosarcoma (OS) is the pretty common primary cancer of the bone among the malignancies in adolescents. A single molecular component or a limited number of molecules is insufficient as a predictive biomarker of OS progression. Hence, it is necessary to find novel network biomarkers to improve the prediction and therapeutic effect for OS. Here, we identified 230 DE-miRNAs and 821 DE-mRNAs through two miRNA expression-profiling datasets and three mRNA expression-profiling datasets. We found that hsa-miR-494 is closely linked with the survival of OS patients. In addition, we analyzed GO and KEGG enrichment for targets of hsa-miR-494-5p and hsa-miR-494-3p through R programming. And five mRNAs were predicted as common targets of hsa-miR-494-5p and hsa-miR-494-3p. We further revealed that upregulated TRPS1 was strongly correlated with poor outcomes in OS patients through the survival analysis based on the TARGET database. The qRT-PCR study verified that the expression of hsa-miR-494-5p and hsa-miR-494-3p was declined considerably, while TRPS1 was notably raised in OS cells when compared to the osteoblasts. Thus, we generated a new regulatory subnetwork of key miRNAs and target mRNAs using Cytoscape software. These results indicate that the novel miRNA-mRNA subnetwork composed of hsa-miR-494-5p, hsa-miR-494-3p, and TRPS1 might be a characteristic molecule for assessing the prognostic value of OS patients.

Citing Articles

Therapeutic Potential of Feline Adipose-Derived Stem Cell Exosomes in the Treatment of Feline Idiopathic Cystitis: A Characterization and Functional Analysis of miRNA Content.

Rubini A, Zanotti F, Licastro D, Calogero G, Bettini G, Piccoli C Nanotheranostics. 2025; 9(1):38-51.

PMID: 39744099 PMC: 11667565. DOI: 10.7150/ntno.99383.


Screening and identification of susceptibility genes for osteosarcoma based on bioinformatics analysis.

Lu Z, Xu J, Cao B, Jin C Ann Transl Med. 2023; 11(2):87.

PMID: 36819543 PMC: 9929789. DOI: 10.21037/atm-22-6369.

References
1.
Jansson M, Lund A . MicroRNA and cancer. Mol Oncol. 2012; 6(6):590-610. PMC: 5528350. DOI: 10.1016/j.molonc.2012.09.006. View

2.
Malik T, Shoichet S, Latham P, Kroll T, Peters L, Shivdasani R . Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1. EMBO J. 2001; 20(7):1715-25. PMC: 145487. DOI: 10.1093/emboj/20.7.1715. View

3.
Zhao H, Yan P, Wang J, Zhang Y, Zhang M, Wang Z . Clinical significance of tumor miR-21, miR-221, miR-143, and miR-106a as biomarkers in patients with osteosarcoma. Int J Biol Markers. 2019; 34(2):184-193. DOI: 10.1177/1724600819843537. View

4.
Bosma S, Wong K, Paul L, Gerbers J, Jutte P . A Cadaveric Comparative Study on the Surgical Accuracy of Freehand, Computer Navigation, and Patient-Specific Instruments in Joint-Preserving Bone Tumor Resections. Sarcoma. 2018; 2018:4065846. PMC: 6260549. DOI: 10.1155/2018/4065846. View

5.
Liborio-Kimura T, Jung H, Chan E . miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer. Oral Oncol. 2014; 51(2):151-7. DOI: 10.1016/j.oraloncology.2014.11.019. View